These lab-built solutions were not made with recreational use in mind. In the 1990s, John W. Huffman and also a team of fellow chemists at Clemson University developed some of the first formulation for synthetic cannabinoid receptor agonists (SCRAs), a household of substances that imitate the physiological and psychological impacts of cannabis on o